Right ventricular disarticulation for arrythmogenic right ventricular dysplasia: an 18 year single centre experience. J Zacharias, J Forty, C Doig*, J.

Slides:



Advertisements
Similar presentations
Hypertrophic Cardiomyopathy Guidelines Summary from the: ACC/ESC Clinical Expert Consensus Statement on Hypertrophic Cardiomyopathy Maron BJ, et al. J.
Advertisements

IMPANTABLE CARDIOVERTER DEFIBRILLATORS (ICDs) Janet McComb Freeman Hospital Newcastle upon Tyne.
ICD FOR PRIMARY PREVENTION EVIDENCE REVIEW
Boston Children’s Hospital, Harvard Medical School
Audit of ablation procedures for AF Barts and The London.
Arrhytmia In Heart Failure
The role of surgery in the management of mesothelioma Mr Martyn Carr Consultant Thoracic Surgeon Liverpool Heart and Chest Hospital.
Cardiac Arrest Mirna Gonzalez Ninth Grade- 14 years of age.
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Although rare, there have been reported cases of antihistamine, cocaine, and psychotropic drug induced Brugada Syndrome. Loperamide is another agent that.
Elsevier items and derived items © 2006 by Elsevier Inc. Chapter 37 Interventions for Clients with Dysrhythmias.
EP Show – Aug 2003 ICDs – Primary prevention The EP Show: Which ICD for which patient? Part 2: Primary prevention Eric Prystowsky MD Director, Clinical.
Lesson 4 What is the treatment for Coronary Artery Disease?
Sudden Cardiac Death; Invasive Evaluation Alpay Çeliker MD Hacettepe University Department of Pediatric Cardiology Ankara, Türkiye.
Devices and the older patient with syncope Michael Gammage, Reader in Cardiovascular Medicine MHRA Committee for Safety of Devices.
Pt’s treated with B-blockers post infarction are seen to have a significant reduction in re-infraction.
Introduction Most patients undergoing left ventricular assist device (LVAD) implantation for destination therapy (DT) also have an implantable cardioverter.
Arrhythmogenic Right Ventricular Dysplasia Georgia Giakoumis Spear, M.D. April 10, 2007.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
A. Marc Gillinov, MD For the Cardiothoracic Surgical Trials Network (CTSN) ACC April 2016 RATE VERSUS RHYTHM CONTROL FOR ATRIAL FIBRILLATION AFTER CARDIAC.
Palpitations & Atrial Fibrillation Dr Mehul B Dhinoja, Consultant Cardiologist & Electrophysiologist BMI The London Independent Hospital.
Implantable Cardioverter Defibrillator (ICD) Reprogramming Guidelines Lauren Butler.
THE HEART’S ELECTRICAL SYSTEM Marco Perez, MD Center for Inherited Cardiovascular Disease Inherited Cardiac Arrhythmia Clinic June 20, 2013.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for Management of Patients.
ATRIAL ESOPHAGEAL FISTULA SECONDARY TO ABLATION FOR ATRIAL FIBRILLATION: A CASE SERIES AND REVIEW OF THE LITERATURE 1 Lily K. Fatula, BS; 1,2 William D.
Carolinas Medical Center, Charlotte, NC Website:
Ethical Scenario: Cardiovascular System
James S. Tweddell, MD Warren W. Bailey Endowed Chair,
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.
Sudden Cardiac Arrest Morhaf Ibrahim, MD, FHRS Electrophysiology.
Minimally Invasive Mitral Valve Repair
Esophagectomy for cancer:
Fontan Global Case Conference Richard J. Czosek, MD 6/28/17
DANTE PAZZANESE INSTITUTE OF CARDIOLOGY, SÃO PAULO, BRAZIL
Joseph Zacharias & Bilal Kirmani Lancashire Cardiac Centre Blackpool
Obstructive Hypertrophic Cardiomyopathy
Atrial Fibrillation: When Should You Consider Ablation?
Simon A. Castro, MD; Daniele Muser, MD; Erica Zado, PA; Rajeev K
Is There a Need to Address AF in patients Undergoing Valve Surgery?
Next-generation sequencing increases the diagnostic yield in aborted sudden cardiac death caused by hereditary heart disease   Brøndberg AK1, Christiansen.
Dr M B Connellan Stellenbosch University
Successful Cox Maze Procedure During Mitral Valve Surgery Restores Patient Survival Without Increasing Operative Risk Niv Ad, MD Chief, Cardiac Surgery.
Pre-Operative Inotropes:
THE “UNDER-LINING” CAUSE OF RIGHT HEART FAILURE AFTER CARDIAC SURGERY
In the name of God.
15th November 2017 James Holmes
The Atrial Fibrillation Clinic in Llanelli
NCEPOD Launch Too Lean a Service
BENEFIT Trial design: Patients with positive serologic tests for T. Cruzi and cardiomyopathy were randomized to benznidazole 300 mg daily for days.
HYPERTROPHIC CARDIOMYOPATHY(HCM)
The EP show: sudden death, part 1 Director
Objectives Early initiation of continuous renal replacement therapy
Left ventricular dilatation, the presence of intra-cardiac thrombus and short term outcome for primary heart graft failure patients managed with ECMO.
Noriko Kikuchi et al. JACEP 2016;2:
Sorin Bicarbon: 17 years of clinical use
Age-related cumulative incidence for (A) serious adverse events (including death, heart failure admission, ventricular arrhythmia and cardiac transplant)
European Heart Association Journal 2007 April
David D. Berg et al. JACC 2018;71:
Surgery for Ventricular Tachycardia in Patients Undergoing Left Ventricular Reconstruction by the Dor Procedure  Ulrik Sartipy, MD, Anders Albåge, MD,
ΝΟΣΟΣ ΤΑΧΥΒΡΑΔΥΚΑΡΔΙΑΣ: ΕΜΦΥΤΕΥΣΗ ΒΗΜΑΤΟΔΟΤΗ Η ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ ; ΓΕΩΡΓΙΟΣ ΣΤΑΥΡΟΠΟΥΛΟΣ ΕΠ.Α ΚΑΡΔΙΟΛΟΓΟΣ ΓΝΘ ΙΠΠΟΚΡΑΤΕΙΟ.
David F. Katz et al. JACEP 2016;j.jacep
Mohit K. Turagam et al. JACEP 2017;3:
Mahesh Anantha Narayanan et al. JACEP 2017;3:
David F. Katz et al. JACEP 2017;3:20-28
(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.
Jerry D. Estep et al. JCHF 2013;1:
Mahesh Anantha Narayanan et al. JACEP 2017;j.jacep
Daniele Muser et al. JACEP 2017;j.jacep
(A). (A). Kaplan-Meier plot of event-free survival in 27 LMNA mutation carriers and 78 DCM control patients. Death, heart transplantation, resuscitation.
Survival free of atrial fibrillation after implantation of an implantable cardioverter defibrillator in our series (151 patients): overall population (solid.
Presentation transcript:

Right ventricular disarticulation for arrythmogenic right ventricular dysplasia: an 18 year single centre experience. J Zacharias, J Forty, C Doig*, J Bourke*, CJ Hilton. Departments of academic cardiology and cardiac surgery, Freeman Hospital, Newcastle upon Tyne. England.

ARVD A Type of cardiomyopathy Affects all age groups Presentation with syncope / sudden death Ventricular Tachycardia / Fibrillation Familial occurrence Structural changes in R V Myocardium

Histology

Treatment options with ARVD patients: Antiarrhythmic medication Percutaneous catheter ablation Automatic internal cardiac defibrillators. (AICD) Surgery

Right Ventricular Disarticulation Described initially by Guiraudon Animal studies done by Guiraudon & Cox et al Medium term results from Cox and Hilton et al Few surgical reports lately

Retrospective Case series: Institution: Tertiary referral centre : Freeman hospital. Time Frame: July 1985 - July 2003. Patient Numbers: 17, age range (14 - 72), 15 M / 2 F Surgeons: CJ Hilton (14) & J Forty (3)

Pre Op Details: Presentation: Management; Syncope: 12 Intractable VT : 3 patients Electrical storms (AICD): 2 Management; Drugs: 17 (Range 3 - 8) EPS: 17 AICD: 2 Echo: 14 Angio; 14 CT Scan: 2

Preop Echo Of ARVD patient

Operative details: Complete: 10 Partial: 7 Full Cardiopulmonary Bypass Cold Blood Cardioplegia Induce VT in the disarticulated segment

Gross Appearance Of ARVD Heart

Completed RV Disarticulation

Post operative events: immediate I Mortality : 1 (6%) multi-organ failure Overall complication rate: 64% (11/17) Reopening for bleeding: 4 Renal failure: 3 Tracheostomy: 2 Derangement of liver function: 1 Pleural effusions: 3

Post operative events: immediate II Mean post -operative hospital stay : 17.6 days (range 9 - 35 days) Electrophysiological studies : 16 Medication at discharge: Anticoagulation: 4 Antiarrhythmic drugs: 2 Digoxin & Diuretics: 6 Biventricular pacing : 2

Post operative events: medium term Further VT episodes : 4 Partial 3/7 Complete 1/10 Supraventricular Tachycardia: 10

Echo findings14 yrs post RV Disarticulation.

Post operative Events: Long Term Follow up : 94% (15/16) 1 lost to follow up alive & well at 5 years. Median 13 years (range 0 - 18) Death: 3 ( 9,11, 17 years post op) Transplantation: 2 ( 3, 8 yrs post op) Awaiting transplantation: 2 ( 3, 14 yrs post op)

Kaplan-Meier actuarial survival 100 1 6 1 5 1 4 1 3 80 1 2 1 1 Survival % 60 40 20 5 10 1 5 2 S u r v i v a l i n y e a r s

Discussion points: Natural history of ARVD Prevention of sudden death Affects young patients Biventricular failure affects some Heart transplantation Prevention of sudden death Can occur despite AICD International registry details awaited Long term effects of biventricular pacing

Effects of Right ventricular pacing

Conclusions: Excellent antiarrhythmic procedure 77% event free survival at 10 years Heart failure may be related to natural history of ARVD Consider as an option in young patients with ARVD who cannot be managed with medication or AICD